Publication
Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting
Downloadable Content
- Persistent URL
- Last modified
- 05/21/2025
- Type of Material
- Authors
- Language
- English
- Date
- 2017-05-01
- Publisher
- Lippincott, Williams & Wilkins
- Publication Version
- Copyright Statement
- © 2017 The Author(s). Published by Wolters Kluwer Health, Inc.
- Final Published Version (URL)
- Title of Journal or Parent Work
- ISSN
- 1525-4135
- Volume
- 75
- Issue
- 1
- Start Page
- 128
- End Page
- 136
- Grant/Funding Information
- This work was supported by the National Institute of Allergy and Infectious Diseases and the National Institute of Child Health and Human Development at the National Institutes of Health [K23 AI 120793-01 and T32 AI07140 to SML, K23 AI 85036-01 to DJH, K24 HD054314-06 to GJS, K12 HD000850 to LMC], University of Washington Center for AIDS Research (CFAR) P30AI027757 to SML, UW INTERSECT-Ellison Fellowship to SML, the National Center for Research Resources at the National Institutes of Health [UL1TR000423] and the Firland Foundation.
- Supplemental Material (URL)
- Abstract
- Background: Peripartum immunologic changes may affect latent tuberculosis infection (LTBI) diagnostic performance among HIVinfected women. Methods: HIV-infected women were serially tested with tuberculin skin test (TST) and interferon gamma release assay [QuantiFERON TB Gold In-tube (QFT)] in pregnancy and 6 weeks postpartum in Kenya. Prevalence, sensitivity and agreement, and correlates of QFT/TST positivity were assessed. Quantitative QFT mitogen and Mycobacterium tuberculosis antigen (Mtb-Ag) responses were compared by peripartum stage. Incidence of test conversion at 6 weeks postpartum was evaluated in baseline TST2/QFT2 women. Results: Among 100 HIV-infected women, median age was 26 years, median CD4 was 555 cells per cubic millimeter, and 88% were on antiretrovirals. More women were QFT+ than TST+ in both pregnancy (35.4% vs. 13.5%, P = 0.001) and postpartum (29.6% vs. 14.8%, P , 0.001). Among 18 consistently QFT+ women, 8 (44%) converted from TST2 to TST+, with improved test agreement postpartum (56.9%, k = 0.20 to 82.4%, k = 0.60). Three initially QFT2/TST2 women had test conversion (TST+ and/or QFT+), suggesting new infection (incidence 13.4/100 person-years). Mean QFT mitogen (4.46 vs. 7.64 IU/mL, P , 0.001) and Mtb-Ag (1.03 vs. 1.54 IU/mL, P = 0.03) responses were lower among all women retested in pregnancy vs. postpartum, and specifically among persistently QFT+ women (Mtb-Ag: 3.46 vs. 4.48 IU/mL, P = 0.007). QFT indeterminate rate was higher in pregnancy (16%) compared with postpartum (0%) because of lower mitogen response. Conclusions: QFT identified .2-fold more women with LTBI compared with TST in pregnancy and postpartum. Lower QFT Mtb-Ag and mitogen responses in pregnancy compared with postpartum suggest that pregnancy-associated immunologic changes may influence LTBI test performance.
- Author Notes
- Keywords
- tuberculin skin testing
- Infectious Diseases
- Science & Technology
- PREVALENCE
- latent tuberculosis infection
- ADOLESCENTS
- PERFORMANCE
- interferon gamma release assay
- Life Sciences & Biomedicine
- INDIVIDUALS
- COMMUNITY
- diagnostics
- DIAGNOSIS
- ACTIVE TUBERCULOSIS
- HIV
- pregnancy
- POSTPARTUM WOMEN
- QuantiFERON TB Gold In-tube
- Immunology
- MORTALITY
- TEST CONVERSION
- Research Categories
- Health Sciences, Obstetrics and Gynecology
- Biology, Biostatistics
- Health Sciences, Immunology
Tools
- Download Item
- Contact Us
-
Citation Management Tools
Relations
- In Collection:
Items
| Thumbnail | Title | File Description | Date Uploaded | Visibility | Actions |
|---|---|---|---|---|---|
|
|
Publication File - s9h96.pdf | Primary Content | 2025-03-15 | Public | Download |